Literature DB >> 31771450

Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.

Darren Wethington1, Olivia Harder2, Karthik Uppulury1, William C L Stewart1,3,4, Phylip Chen5, Tiffany King5,6, Susan D Reynolds7,3, Alan S Perelson8, Mark E Peeples5,3,6, Stefan Niewiesk2, Jayajit Das1,3,9,10.   

Abstract

Respiratory syncytial virus (RSV) is a common virus that can have varying effects ranging from mild cold-like symptoms to mortality depending on the age and immune status of the individual. We combined mathematical modelling using ordinary differential equations (ODEs) with measurement of RSV infection kinetics in primary well-differentiated human bronchial epithelial cultures in vitro and in immunocompetent and immunosuppressed cotton rats to glean mechanistic details that underlie RSV infection kinetics in the lung. Quantitative analysis of viral titre kinetics in our mathematical model showed that the elimination of infected cells by the adaptive immune response generates unique RSV titre kinetic features including a faster timescale of viral titre clearance than viral production, and a monotonic decrease in the peak RSV titre with decreasing inoculum dose. Parameter estimation in the ODE model using a nonlinear mixed effects approach revealed a very low rate (average single-cell lifetime > 10 days) of cell lysis by RSV before the adaptive immune response is initiated. Our model predicted negligible changes in the RSV titre kinetics at early times post-infection (less than 5 dpi) but a slower decay in RSV titre in immunosuppressed cotton rats compared to that in non-suppressed cotton rats at later times (greater than 5 dpi) in silico. These predictions were in excellent agreement with the experimental results. Our combined approach quantified the importance of the adaptive immune response in suppressing RSV infection in cotton rats, which could be useful in testing RSV vaccine candidates.

Entities:  

Keywords:  adaptive immunity; cotton rats; nonlinear mixed effects modelling; ordinary differential equations; respiratory syncytial virus; viral kinetics

Mesh:

Year:  2019        PMID: 31771450      PMCID: PMC6893489          DOI: 10.1098/rsif.2019.0389

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  54 in total

1.  SURVIVAL OF THE RESPIRATORY SYNCYTIAL VIRUS DURING STORAGE UNDER VARIOUS CONDITIONS.

Authors:  M H HAMBLING
Journal:  Br J Exp Pathol       Date:  1964-12

2.  Towards a quantitative understanding of the within-host dynamics of influenza A infections.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

3.  Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.

Authors:  Marc Lavielle; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-01-09       Impact factor: 2.745

4.  The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

Authors:  Martin G Ottolini; Jorge C G Blanco; Maryna C Eichelberger; David D Porter; Lioubov Pletneva; Joann Y Richardson; Gregory A Prince
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

5.  Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection.

Authors:  M Gia Green; Natasha Petroff; Krista M D La Perle; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

Review 6.  Bronchiolitis.

Authors:  Rosalind L Smyth; Peter J M Openshaw
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

7.  The pathogenesis of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; A B Jenson; R L Horswood; E Camargo; R M Chanock
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

8.  Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection.

Authors:  Philip R Wyde; Srikrishna N Chetty; Philip Timmerman; Brian E Gilbert; Koen Andries
Journal:  Antiviral Res       Date:  2003-11       Impact factor: 5.970

Review 9.  Respiratory syncytial virus--viral biology and the host response.

Authors:  D Hacking; J Hull
Journal:  J Infect       Date:  2002-07       Impact factor: 6.072

Review 10.  Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics.

Authors:  Natalie I Mazur; Federico Martinón-Torres; Eugenio Baraldi; Brigitte Fauroux; Anne Greenough; Terho Heikkinen; Paolo Manzoni; Asuncion Mejias; Harish Nair; Nikolaos G Papadopoulos; Fernando P Polack; Octavio Ramilo; Mike Sharland; Renato Stein; Shabir A Madhi; Louis Bont
Journal:  Lancet Respir Med       Date:  2015-09-25       Impact factor: 30.700

View more
  6 in total

Review 1.  Mechanistic Modeling of SARS-CoV-2 and Other Infectious Diseases and the Effects of Therapeutics.

Authors:  Alan S Perelson; Ruian Ke
Journal:  Clin Pharmacol Ther       Date:  2021-03-08       Impact factor: 6.875

2.  Quantification of Ebola virus replication kinetics in vitro.

Authors:  Laura E Liao; Jonathan Carruthers; Sophie J Smither; Simon A Weller; Diane Williamson; Thomas R Laws; Isabel García-Dorival; Julian Hiscox; Benjamin P Holder; Catherine A A Beauchemin; Alan S Perelson; Martín López-García; Grant Lythe; John N Barr; Carmen Molina-París
Journal:  PLoS Comput Biol       Date:  2020-11-02       Impact factor: 4.475

3.  Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats.

Authors:  Margaret E Martinez; Cristina Capella Gonzalez; Devra Huey; Mark E Peeples; Douglas McCarty; Stefan Niewiesk
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 4.  Respiratory Syncytial Virus Infection Modeled in Aging Cotton Rats (Sigmodon hispidus) and Mice (Mus musculus).

Authors:  Olivia E Harder; Stefan Niewiesk
Journal:  Adv Virol       Date:  2022-03-09

5.  SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?

Authors:  Lubna Pinky; Hana M Dobrovolny
Journal:  J Med Virol       Date:  2020-06-19       Impact factor: 20.693

6.  Immune-viral dynamics modeling for SARS-CoV-2 drug development.

Authors:  Youfang Cao; Wei Gao; Luzelena Caro; Julie A Stone
Journal:  Clin Transl Sci       Date:  2021-07-08       Impact factor: 4.438

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.